Cycc short interest
WebApr 6, 2024 · CYCC Earnings Date and Information. Cyclacel Pharmaceuticals last issued its quarterly earnings results on March 6th, 2024. The biotechnology company reported ($0.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.48) by $0.12. Cyclacel Pharmaceuticals has generated ($1.90) earnings per share over the … WebJan 27, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 …
Cycc short interest
Did you know?
WebCyclacel Pharmaceuticals, Inc. Analyst Report: Johnson & Johnson Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: … WebCYCC's second split took place on May 31, 2016. This was a 1 for 12 reverse split, meaning for each 12 shares of CYCC owned pre-split, the shareholder now owned 1 share. For …
WebApr 9, 2024 · 2 brokerages have issued 12 month price targets for Cyclacel Pharmaceuticals' stock. Their CYCC share price forecasts range from … WebIntroduction. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at …
WebIn depth view into Cyclacel Pharmaceuticals Short Interest including historical data from 2006, charts and stats. ... View Short Interest for CYCC. Upgrade now. Sep '18. Jan '19. May '19 . 285.00. 270.00. 255.00. 240.00. Historical Short Interest Data. View and export this data back to 2006. WebThe Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...
WebFind the latest on short interest for Cyclacel Pharmaceuticals, Inc. Common Stock (CYCC) at Nasdaq.com. Cyclacel Pharmaceuticals, Inc. Common Stock (CYCC) Short Interest …
WebThomson Reuters StreetEvents -6.63%. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment ... klondike daily challenge solitaireWebMembers receive 2 years of Historical Short Interest data (older historical data is available for purchase by members). Each report includes a comprehensive collection of in-depth short interest details. After every published short interest release, the data is compiled and made available for members to download and use (in Excel format). klondike expedition sign inWebCompany’s earnings for a period net of operating costs, taxes, and interest. -7.42M. -40.14%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue ... klondike equipment boy scoutsWebMar 10, 2024 · Short interest is the volume of Cyclacel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 461,800 shares of … red and orange color meaningWebFind the latest on short interest for Cyclacel Pharmaceuticals, Inc. Common Stock (CYCC) at Nasdaq.com. red and orange cloudsWebApr 5, 2024 · View real-time CYCC stock price and news, along with industry-best analysis. ... Short Interest: 493.13K (02/28/23)Short Interest Change-5.57%: Percent of Float: 4.36%: Advanced $ 1D. Compare. red and orange color blind testWebApr 6, 2024 · fool.com - October 14 at 5:10 PM. Cyclacel Pharmaceuticals To Present Preliminary Data From The Phase 1/2 Clinical Trial Of Oral Fadraciclib At The 34th EORTC-NCI-AACR Symposium. finance.yahoo.com - October 13 at 9:50 AM. Cyclacel stock rises 16% as net loss narrows, income grows. red and orange complementary colors